Press Releases about Angiodynamics Inc
![](https://www.businesswire.com/images/bwlogo_extreme.png)
AngioDynamics Announces CE Mark Approval in Europe for the Auryon System
September 03, 2024
From AngioDynamics, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20240729308520/en/2199226/5/ANGO_Logo.jpg)
From AngioDynamics, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20240716644861/en/2186610/22/angiologo.jpg)
![](https://mms.businesswire.com/media/20240709446033/en/2179764/5/ANGO_-_Logo.jpg)
![](https://mms.businesswire.com/media/20240521113985/en/664620/5/ANGO_-_Logo.jpg)
![](https://mms.businesswire.com/media/20240506582349/en/664620/5/ANGO_-_Logo.jpg)
![](https://mms.businesswire.com/media/20240404578502/en/664620/5/ANGO_-_Logo.jpg)
![](https://mms.businesswire.com/media/20240404798384/en/664620/5/ANGO_-_Logo.jpg)
![](https://mms.businesswire.com/media/20240401305298/en/664620/5/ANGO_-_Logo.jpg)
![](https://mms.businesswire.com/media/20240319173188/en/664620/5/ANGO_-_Logo.jpg)
![](https://mms.businesswire.com/media/20240306337982/en/664620/5/ANGO_-_Logo.jpg)
![](https://mms.businesswire.com/media/20240215583083/en/664620/5/ANGO_-_Logo.jpg)
![](https://mms.businesswire.com/media/20240123524948/en/664620/5/ANGO_-_Logo.jpg)
![](https://mms.businesswire.com/media/20240105416764/en/664620/5/ANGO_-_Logo.jpg)
![](https://mms.businesswire.com/media/20231221815072/en/664620/5/ANGO_-_Logo.jpg)
AngioDynamics to Present at the J.P. Morgan Healthcare Conference
December 21, 2023
From AngioDynamics, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20231207004997/en/664620/5/ANGO_-_Logo.jpg)
![](https://mms.businesswire.com/media/20231207708613/en/664620/5/ANGO_-_Logo.jpg)
![](https://mms.businesswire.com/media/20231004330619/en/664620/5/ANGO_-_Logo.jpg)
![](https://mms.businesswire.com/media/20230912744291/en/664620/5/ANGO_-_Logo.jpg)
AngioDynamics to Report Fiscal 2024 First Quarter Financial Results on October 4, 2023
September 12, 2023
From AngioDynamics, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20230815110351/en/664620/5/ANGO_-_Logo.jpg)
![](https://mms.businesswire.com/media/20230803091690/en/664620/5/ANGO_-_Logo.jpg)
AngioDynamics Completes Enrollment for PRESERVE Clinical Study
August 03, 2023
From AngioDynamics, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20230731261073/en/664620/5/ANGO_-_Logo.jpg)
![](https://mms.businesswire.com/media/20230724751181/en/664620/5/ANGO_-_Logo.jpg)
![](https://mms.businesswire.com/media/20230712983563/en/664620/5/ANGO_-_Logo.jpg)
![](https://mms.businesswire.com/media/20230620458519/en/664620/5/ANGO_-_Logo.jpg)
![](https://mms.businesswire.com/media/20230608005725/en/664620/5/ANGO_-_Logo.jpg)
![](https://mms.businesswire.com/media/20230411005783/en/664620/5/ANGO_-_Logo.jpg)
From AngioDynamics, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20230330005189/en/664620/5/ANGO_-_Logo.jpg)
![](https://mms.businesswire.com/media/20230313005747/en/664620/5/ANGO_-_Logo.jpg)
![](https://mms.businesswire.com/media/20230228005538/en/664620/5/ANGO_-_Logo.jpg)
AngioDynamics to Participate in Three Investor Conferences in March
February 28, 2023
From AngioDynamics, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.